1. Amada N, Lea T, Letheby C, Shane J (2020) Psychedelic experience and the narrative self: an exploratory qualitative study. J Conscious Stud 27:6–33
2. American Psychiatric Association (1980) DSM-III: diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington DC
3. Bahr R, Lopez A, Rey JA (2019) Intranasal esketamine (SpravatoTM) for use in treatment-resistant depression in conjunction with an oral antidepressant. P T 44:340–375
4. Ballard ED, Zarate CA (2020) The role of dissociation in ketamine’s antidepressant effects. Nat Commun 11:6431. https://doi.org/10.1038/s41467-020-20190-4
5. Bennett R, Yavorsky C, Bravo G (2022) Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches. Front Psychiatry 13. https://doi.org/10.3389/fpsyt.2022.867484